Free Sign up
The Latest

French Healthcare SPAC eureKING Looking to Combine with Skyepharma

May 16, 2023
1 minute read
Total
0
Shares
0
0
0

eureKING, the first European SPAC in healthcare focused on bioproduction, today announced that it has submitted a firm offer for an exclusive period to evaluate the acquisition Skyepharma, a 27-year-old French company engaged in drug development.

The SPAC raised €150 million (about US $164 million) in May 2022 and lists on the  Euronext Paris.

BNP Paribas and Société Générale Corporate & Investment Banking are financial advisors to eureKING and Willkie Farr & Gallagher and Linklaters are legal advisors to eureKING.

Claris Avocats is legal advisor to Skyepharma.

.

Total
0
Shares
Share 0
Tweet 0
Share 0
Related Posts
Read More

Maxpro Capital Acquisition Shareholders Approve Apollomics Deal

The SPAC also noted that 10,270,060 shares were redeemed in connection with the vote. That essentially wiped out Maxpro's cash in trust, which originally stood at $105 million. However, last month the SPAC announced PIPE subscriptions totaling $23.65 million -- more than enough to cover the $20 million minimum to close the deal.